EEG Frequency-Band Metrics for Detecting GABAergic Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing neuropsychiatric disorders like autism spectrum disorder (ASD) are hindered by unclear pathophysiology and variability in EEG signatures, making it difficult to identify patient subgroups responsive to specific drug modes of action.
Innovation Solution
A method using electroencephalography (EEG) to detect GABAergic dysfunction by analyzing a specific frequency range of brain oscillatory activity, correcting for background signal to identify GABA-A receptor dysfunction and directionality, enabling sensitive detection of GABAergic status and responsiveness to GABA modulators.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If EEG signals are used to identify neuropsychiatric disorders, then diagnostic information can be obtained, but individual characteristics and variability lead to unclear pathophysiology and difficulty in identifying patient subgroups
Solution Approach 1:
The patent segments the EEG power spectrum into distinct frequency bands (delta, theta, alpha, beta, gamma) to isolate specific oscillatory patterns associated with different pathophysiological states. By analyzing specific frequency ranges rather than the entire spectrum, the method identifies distinct patient subgroups with characteristic EEG signatures, improving both diagnostic precision and pathophysiology clarity.
Solution Approach 2:
The patent applies local quality by focusing on specific frequency bands and regions of the EEG spectrum that are locally characteristic of particular neurological conditions. Instead of treating the entire EEG signal uniformly, the method identifies and analyzes specific local patterns (e.g., beta band oscillations) that provide diagnostic information about GABAergic dysfunction and patient subgroup characteristics.
2Quantity of substance
If general EEG analysis is performed, then overall brain activity can be measured, but specific pathophysiology cannot be identified due to heterogeneous aetiologies
Solution Approach 1:
The patent segments the EEG analysis by frequency band, allowing specific pathophysiological patterns to be identified within the heterogeneous data. By dividing the spectrum into distinct bands and analyzing each separately, the method can identify specific oscillatory patterns that correlate with particular aetiologies and patient subgroups, improving pathophysiology identification precision.
Solution Approach 2:
The patent utilizes parameter changes by analyzing variations in power spectral density across different frequency bands and comparing them against reference ranges. By monitoring changes in specific parameters (e.g., beta band power) and their deviations from normal ranges, the method identifies specific pathophysiological states and predicts responsiveness to treatments targeting particular mechanisms.
3Productivity
If treatment is prescribed without identifying specific pathophysiology, then general treatment can be administered, but treatment efficacy is reduced due to unknown aetiology
Solution Approach 1:
The patent implements feedback by using EEG-based pathophysiology identification to guide treatment selection and monitor treatment response. The method provides feedback information about specific neurological dysfunction characteristics that can be used to select appropriate treatments and adjust therapy based on identified patient subgroup characteristics, improving treatment responsiveness and efficacy.
Solution Approach 2:
The patent applies preliminary action by identifying pathophysiological characteristics and patient subgroups before treatment initiation. By performing EEG analysis and identifying specific oscillatory patterns in advance, the method enables targeted treatment selection that is tailored to the individual's neurological profile, improving treatment efficacy from the outset.
Data Source
AI summary
The invention provides a method of determining whether a subject has a neurological dysfunction associated with a signal in a particular electroencephalogram (EEG) or magnetoencephalogram (MEG) frequency range, the method comprising: obtaining an EEG power spectrum from the subject; and obtaining a metric quantifying the magnitude of power in particular frequency range metric quantifying the power in the power spectrum in the particular frequency range, wherein the metric summarises the power in said frequency range corrected using an estimate of the power in said frequency range that is attributable to background signal that is specific to said frequency range, wherein the metric is indicative of the presence and/or severity and/or direction of a neurological dysfunction. Related methods and devices are also described.